Skip to main content

The independent medical news service

09-02-2021 | Oncology | Highlight | Article

​​​​​​​TALENT supports low-dose CT screening for high-risk never smokers

The Taiwan Lung Cancer Screening in Never-Smoker Trial suggests that low-dose computed tomography screening may help to detect early-stage disease in never smokers at high risk for developing lung cancer.

08-02-2021 | Oncology | News | Article

ITACA pharmacogenomic adjuvant chemotherapy approach does not boost resected NSCLC outcomes

Non-small-cell lung cancer survival after complete resection was not improved by use of mRNA expression levels of two genes to guide choice of adjuvant chemotherapy, shows research reported at the IASLC 2020 World Conference on Lung Cancer.

05-02-2021 | Oncology | News | Article

Tepotinib approved for NSCLC with MET exon 14 mutations

Read more about this US FDA decision here

05-02-2021 | Oncology | News | Article

Emerging options for NSCLC with rare EGFR mutations

Promising early data on several novel treatment options for non-small-cell lung cancer harboring rare EGFR alterations have been reported at the IASLC 2020 World Conference on Lung Cancer.

04-02-2021 | Oncology | News | Article

Novel immune agent shows early promise in SCLC

AMG 757, a half-life extended, bispecific T-cell engager immunotherapy directed against DLL3, has demonstrated tolerability and antitumor activity in patients with previously treated small-cell lung cancer in a phase 1 trial.

03-02-2021 | Oncology | News | Article

LCMC3 results point to early NSCLC response with neoadjuvant atezolizumab

Two cycles of neoadjuvant atezolizumab may benefit patients with resectable non-small-cell lung cancer, indicate findings from the LCMC3 study presented at the IASLC 2020 World Conference on Lung Cancer.

Image Credits